EU vs REGN · rev $13.4M vs P/E 14, rev $14.34B
enCore Energy Corp. Common Shares (EU) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
enCore Energy Corp. Common Shares (EU) is a uranium company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EU revenue for 2024-12-31 was $13.4M. Net income was -$17.1M. Revenue was up 44.3% from 2024-09-30 to 2024-12-31. EU currently screens at market cap $268.0M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EU currently screens at market cap $268.0M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EU and REGN stock pages for the full models.
Not investment advice.